Literature DB >> 17804077

Random plasma concentrations of voriconazole decline over time.

Victor Mulanovich1, Russell E Lewis, Issam I Raad, Dimitrios P Kontoyiannis.   

Abstract

We retrospectively collected information about 29 cancer patients who underwent measurement of their plasma concentration (PC) of voriconazole (VRC) (2002-2006). Nine patients (31%) had VRC PC <1 microg/ml. VRC PC <1 microg/ml occurred in 7 of 10 patients who were on VRC >2 months versus only 2 of 19 patients who were on VRC <2 months (P=0.001). VRC PCs were infrequently ordered, did not follow clear indications, and the use of the results was variable.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17804077     DOI： 10.1016/j.jinf.2007.07.019

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  11 in total

1.  Accelerated metabolism of voriconazole and its partial reversal by cimetidine.

Authors:  Brad Moriyama; Jason Elinoff; Robert L Danner; Juan Gea-Banacloche; Gennethel Pennick; Michael G Rinaldi; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

Review 2.  Antifungal therapeutic drug monitoring: established and emerging indications.

Authors:  David Andes; Andres Pascual; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

3.  What is the role of therapeutic drug monitoring in antifungal therapy?

Authors:  Jeannina A Smith
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

4.  What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?

Authors:  Dimitrios P Kontoyiannis; David S Perlin; Emmanuel Roilides; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2013-05-06       Impact factor: 9.079

5.  Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma.

Authors:  Natasha E Holmes; Janine M Trevillyan; Sarah E Kidd; Trishe Y-M Leong
Journal:  Med Mycol Case Rep       Date:  2013-04-19

6.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

7.  A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case.

Authors:  Setareh Davoudi; Paolo Anderlini; Gregory N Fuller; Dimitrios P Kontoyiannis
Journal:  Mycopathologia       Date:  2014-08-03       Impact factor: 2.574

8.  Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.

Authors:  Steven M Trifilio; Paul R Yarnold; Marc H Scheetz; Judy Pi; Gennethel Pennick; Jayesh Mehta
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

Review 9.  Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients.

Authors:  Kevin J Downes; Brian T Fisher; Nicole R Zane
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

10.  A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.

Authors:  Nathan P Wiederhold; Gennethel J Pennick; Sheryl A Dorsey; Wieslaw Furmaga; James S Lewis; Thomas F Patterson; Deanna A Sutton; Annette W Fothergill
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.